Genome-wide association study identifies high-impact susceptibility loci for HCC in North America
Manal M. Hassan(The University of Texas MD Anderson Cancer Center), Pankil Shah(Mays Cancer Center at UT Health San Antonio), Jinyoung Byun(Dartmouth College), Younghun Han(University of New Mexico), Yun Shin Chun(The University of Texas MD Anderson Cancer Center), Jorge A. Marrero(University of Pennsylvania), Jiyeon Choi(Korea University), Amit G. Singal(Southwestern Medical Center), Ernest T. Hawk(The University of Texas MD Anderson Cancer Center), Samuel O. Antwi(Mayo Clinic in Florida), Robin Kate Kelley(UCSF Helen Diller Family Comprehensive Cancer Center), Rikita Hatia(The University of Texas MD Anderson Cancer Center), Sean P. Cleary(University Health Network), R. Mark Ghobrial(Methodist Hospital), Roxana Bucur(University Health Network), Hashem B. El‐Serag(Baylor College of Medicine), Donna L. White(Baylor College of Medicine), Alison P. Klein(Johns Hopkins University), Robert A. Wolff(The University of Texas MD Anderson Cancer Center), Jennifer B. Permuth(Moffitt Cancer Center), Neehar D. Parikh(University of Michigan), Dimpy P. Shah(The University of Texas MD Anderson Cancer Center), Richard D. Kim(Moffitt Cancer Center), Ryan Sun(The University of Texas MD Anderson Cancer Center), Jian Gu(Nantong University), Paige M. Bracci(University of California, San Francisco), Sunyoung S. Lee(The University of Texas MD Anderson Cancer Center), John A. Goss(Texas Children's Hospital), Francisco Cigarroa(The University of Texas at San Antonio Health Science Center), Yuko Kono(University of San Diego), Anna S. Lok(University of Michigan), Prasun K. Jalal(Baylor College of Medicine), Jian‐Min Yuan(University of Pittsburgh), Regina M. Santella(Columbia University), Saira Khaderi(Baylor College of Medicine), Erping Long(Chinese Academy of Medical Sciences & Peking Union Medical College), Laura Beretta(The University of Texas MD Anderson Cancer Center), Karen Zhang(UCSF Helen Diller Family Comprehensive Cancer Center), Donghui Li(The University of Texas MD Anderson Cancer Center), Geoffrey Liu(Princess Margaret Cancer Centre), Asif Rashid(American International University-Bangladesh), Ping Chang(The University of Texas MD Anderson Cancer Center), Hesham M. Amin(The University of Texas MD Anderson Cancer Center), Lu‐Yu Hwang(The University of Texas Health Science Center at Houston), Hui‐Chen Wu(Columbia University), Chad Huff(The University of Texas MD Anderson Cancer Center), Mindie H. Nguyen(Stanford Medicine), Yanan Li(Anhui University), Yehuda Z. Patt(Anderson Hospital), Mikayla A. Schmidt(Mayo Clinic)
Cited by 42
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
|Hepatology|2003|4.3k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k